This is the current release of the guideline.

• Assessment of risk factors for infection with Chlamydia trachomatis should be performed during every routine healthcare contact of sexually active women.
• Sexually active women with risk factors should be screened annually by any well-validated, laboratory-based amplification or antigen method, using cervical or urine specimens. Risk factors include age <25 years, a new male sex partner or two or more partners during the preceding year, inconsistent use of barrier contraception, history of a prior sexually transmitted disease (STD), African-American race, and cervical ectopy. All partners of women with positive tests should be tested for Chlamydia trachomatis. Women with mucopurulent discharge, suggestive of cervicitis, should be tested immediately.
• Pregnant women should be screened during their first trimester or at their first prenatal visit. Those with risk factors should be re-screened during their third trimester.
• Recommended research priorities include well-designed, randomized controlled trials studying the long-term effects of screening and treatment of various populations, prevalence studies of asymptomatic males, and cost-effectiveness studies of office-based rapid tests.

None provided

The type of supporting evidence is not specifically stated for each recommendation.

Not applicable: Guideline was not adapted from another source.

2003 Apr

American College of Preventive Medicine - Medical Specialty Society

American College of Preventive Medicine (ACPM)

Practice Guidelines Committee

Primary Authors: Katerina Hollblad-Fadiman, MD, MPH; Samuel M. Goldman, MD, MPH

Not stated

This is the current release of the guideline.

None available

None available

This NGC summary was completed by ECRI on October 30, 2003. The information was verified by the guideline developer on November 24, 2003.

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.